DBD stock · MS stock

DBD vs MS · P/E 28, rev $3.75B vs P/E 20, $344.27B cap

Diebold Nixdorf, Incorporated (DBD) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.

Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.

Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.

Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.

MS does not have a complete income-statement cache yet.

DBD currently screens at market cap $2.82B and trailing P/E 28.1. MS currently screens at market cap $344.27B and trailing P/E 19.8.

Not investment advice. Open the DBD and MS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons